ARTICLE | Company News
Erasmus University Rotterdam, MDxHealth deal
October 5, 2015 7:00 AM UTC
Erasmus granted MDxHealth exclusive, worldwide rights to use bladder cancer DNA methylation biomarkers for lab-developed tests and in vitro diagnostic products. Erasmus will receive an upfront payment...